US Stock MarketDetailed Quotes
ZVRA Zevra Therapeutics
- 9.140
- +0.170+1.90%
Trading Nov 21 13:33 ET
487.86MMarket Cap-4291P/E (TTM)
9.300High8.900Low242.85KVolume9.040Open8.970Pre Close2.22MTurnover0.56%Turnover RatioLossP/E (Static)53.38MShares9.30052wk High6.99P/B393.75MFloat Cap4.20052wk Low--Dividend TTM43.08MShs Float418.400Historical High--Div YieldTTM4.46%Amplitude2.560Historical Low9.155Avg Price1Lot Size
Zevra Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 27.63%3.7M | -47.47%4.45M | 7.84%3.43M | 170.26%27.46M | 538.97%12.92M | 0.73%2.9M | 551.54%8.47M | -19.90%3.18M | -64.53%10.16M | -21.69%2.02M |
| Operating revenue | 27.63%3.7M | -47.47%4.45M | 7.84%3.43M | 170.26%27.46M | 538.97%12.92M | 0.73%2.9M | 551.54%8.47M | -19.90%3.18M | -64.53%10.16M | -21.69%2.02M |
| Cost of revenue | 1,499.31%2.3M | 427.77%3.57M | 40.00%175K | 1,226.58%2.95M | 8,986.36%2M | 2.13%144K | 1,227.45%677K | 1,462.50%125K | -89.22%222K | -62.71%22K |
| Gross profit | -49.40%1.39M | -88.76%876K | 6.52%3.25M | 146.66%24.52M | 446.05%10.92M | 0.66%2.75M | 523.94%7.79M | -22.90%3.05M | -62.62%9.94M | -20.73%2M |
| Operating expense | 58.42%28.7M | 75.66%24.67M | 49.45%23.74M | 112.74%74.12M | 130.51%26.08M | 93.56%18.12M | -46.01%14.05M | 173.07%15.88M | 84.72%34.84M | 110.87%11.31M |
| Selling and administrative expenses | 178.58%16.21M | 90.62%12.6M | 37.42%9.93M | 128.18%34.31M | 207.15%14.66M | 46.40%5.82M | 85.83%6.61M | 164.34%7.23M | 72.83%15.04M | 86.70%4.77M |
| Research and development costs | -10.99%10.95M | 41.54%10.52M | 41.85%12.28M | 101.01%39.81M | 74.61%11.42M | 128.36%12.3M | -66.90%7.43M | 180.82%8.66M | 94.89%19.8M | 132.86%6.54M |
| Depreciation amortization depletion | --1.55M | --1.55M | --1.53M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Depreciation and amortization | --1.55M | --1.55M | --1.53M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Operating profit | -77.73%-27.31M | -280.60%-23.8M | -59.66%-20.49M | -99.20%-49.6M | -62.75%-15.16M | -131.87%-15.36M | 74.76%-6.25M | -590.21%-12.83M | -422.19%-24.9M | -227.69%-9.31M |
| Net non-operating interest income expense | -192.06%-1.26M | -235.69%-1.84M | -77.44%194K | 158.06%3.04M | -163.41%-546K | 1,359.57%1.37M | 310.91%1.36M | 743.14%860K | 1,124.35%1.18M | 617.50%861K |
| Non-operating interest income | -39.64%1.05M | -82.61%270K | -10.84%929K | 200.13%4.54M | -79.63%210K | 697.25%1.74M | 324.32%1.55M | 873.83%1.04M | 479.69%1.51M | 724.80%1.03M |
| Non-operating interest expense | 531.69%2.31M | 971.07%2.11M | 303.85%735K | 348.06%1.5M | 344.71%756K | 195.16%366K | 447.22%197K | 3,540.00%182K | -10.90%335K | 3,300.00%170K |
| Other net income (expense) | -222.46%-4.66M | 157.00%5.78M | 366.86%3.6M | 116.72%515K | -128.07%-4.19M | 3,349.57%3.8M | 802.81%2.25M | -1,115.32%-1.35M | 80.90%-3.08M | 28,052.83%14.92M |
| Gain on sale of security | -222.46%-4.66M | 157.00%5.78M | 366.86%3.6M | -96.47%515K | -128.07%-4.19M | 3,349.57%3.8M | 802.81%2.25M | -1,115.32%-1.35M | 37,489.74%14.58M | 28,052.83%14.92M |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -9.74%-17.66M | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 9.74%17.66M | --0 |
| Income before tax | -226.05%-33.23M | -650.09%-19.86M | -25.32%-16.69M | -71.79%-46.05M | -407.50%-19.89M | -53.26%-10.19M | 89.31%-2.65M | -613.06%-13.32M | -214.58%-26.81M | 342.38%6.47M |
| Income tax | 0 | 194.59%70K | 32.04%-70K | 0 | 0 | 636.36%177K | 89.65%-74K | -2,475.00%-103K | -197.06%-33K | 2,014.71%719K |
| Net income | -220.49%-33.23M | -674.39%-19.93M | -25.76%-16.62M | -72.00%-46.05M | -445.95%-19.89M | -56.70%-10.37M | 89.30%-2.57M | -609.07%-13.22M | -212.94%-26.77M | 312.73%5.75M |
| Net income continuous Operations | -220.49%-33.23M | -674.39%-19.93M | -25.76%-16.62M | -72.00%-46.05M | -445.95%-19.89M | -56.70%-10.37M | 89.30%-2.57M | -609.07%-13.22M | -212.94%-26.77M | 312.73%5.75M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -220.49%-33.23M | -674.39%-19.93M | -25.76%-16.62M | -72.00%-46.05M | -445.95%-19.89M | -56.70%-10.37M | 89.30%-2.57M | -609.07%-13.22M | -212.94%-26.77M | 312.73%5.75M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -220.49%-33.23M | -674.39%-19.93M | -25.76%-16.62M | -72.00%-46.05M | -445.95%-19.89M | -56.70%-10.37M | 89.30%-2.57M | -609.07%-13.22M | 57.44%-26.77M | 312.73%5.75M |
| Basic earnings per share | -130.00%-0.69 | -500.00%-0.48 | -5.26%-0.4 | -66.67%-1.3 | -437.50%-0.54 | -57.89%-0.3 | 88.57%-0.08 | -660.00%-0.38 | 63.03%-0.78 | 220.00%0.16 |
| Diluted earnings per share | -130.00%-0.69 | -500.00%-0.48 | -5.26%-0.4 | -66.67%-1.3 | -437.50%-0.54 | -57.89%-0.3 | 88.57%-0.08 | -660.00%-0.38 | 63.03%-0.78 | 220.00%0.16 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data